|
|
 |
| |
 It has been a terrific and eventful few months for OneWorld Health. We’ve made exciting progress towards a new cure for visceral leishmaniasis in India, our nonprofit pharmaceutical model has been showcased in leading forums around the world, and our supporters—from individuals to institutions—continue to grow in number and commitment. Take a moment to read our latest news—we hope you will not only be informed, but inspired to play a greater role in this essential global health work.
 
 CEO Hale speaks at the World Economic Forum.
Victoria Hale presented at the Davos governor’s meeting for health care, at a session entitled "The role of the private sector in international efforts to fight AIDS, TB and malaria." She spoke about the need for innovative new and affordable therapies to both prevent and treat AIDS and other neglected diseases.
 “Kill or Cure”: BBC to air documentary on OneWorld Health beginning May 21. Millions of television viewers worldwide will have the opportunity in May to learn just how OneWorld Health intends to cure deadly “kala azar” (visceral leishmaniasis) in India. This past January, a documentary film crew followed Victoria Hale and two Indian experts in leishmaniasis during their visit to rural Bihar, India, where entire villages are battling this ancient and loathsome parasitic disease.
 Donation of University of California, Santa Barbara discovery may accelerate new treatment for schistosomiasis. The University of California, Santa Barbara has donated to OneWorld Health all rights to a patent that covers the novel use of an established class of cardiovascular medicines as a potential new treatment for schistosomiasis.
|
|
 |
 |
|
|
|
